G200217-NCT04605913

Dynamic List Information
Dynamic List Data
Study Title
A Phase I/Ib Pilot Trial, Single Arm, Open Label, of Protein-Bound Paclitaxel, Cisplatin, and Gemcitabine (GCN) Combined With Tumor Treatment Fields (TTF) in Patient With Metastatic Pancreatic Adenocarcinoma
Sponsor Name
Mayo Clinic
NCT Number
NCT04605913
IDE Number
G200217
CMS Approval Date
2023-04-13
Category
A